Literature DB >> 1342058

The management of pediatric brain tumors in a tertiary center.

M Mandel1, A Toren, G Findler, Y Neumann, G Kende, M Faibel, R Tadmor, H Brenner, A Sahar, B Ramot.   

Abstract

Between January 1982 and January 1990, 120 newly diagnosed pediatric patients were treated at The Chaim Sheba Medical Center. Sixty three (52.5%) tumors arose in the posterior fossa and 57 (47.5%) appeared supratentorially. A wide variety of histologic subtypes was seen, each requiring tumor-specific treatment. The modern imaging techniques-CT and MRI-offered better planning of operation, treatment and follow up. All children with highly malignant tumors were treated with combination chemotherapy besides the 'conventional radiotherapy'. Since 1987 the "eight in one day" protocol has been used extensively pre- and post-irradiation. Five-year survival, varied significantly according to tumor type, location and stage. The average delay from presentation of symptoms to diagnosis was 6 months. A multidisciplinary approach has been used in the treatment, rehabilitation and follow-up of these children. In this study, the results of treatment are presented and the role of chemotherapy is discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1342058     DOI: 10.1007/bf02987750

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  17 in total

1.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

2.  Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy.

Authors:  R J Packer; J C Allen; J L Goldwein; J Newall; R A Zimmerman; J Priest; T Tomita; D E Mandelbaum; B H Cohen; J L Finlay
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

3.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

4.  Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.

Authors:  T W Pendergrass; J M Milstein; J R Geyer; A F Mulne; E J Kosnik; J D Morris; R L Heideman; F B Ruymann; J T Stuntz; W A Bleyer
Journal:  J Clin Oncol       Date:  1987-08       Impact factor: 44.544

5.  High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.

Authors:  M A Castello; A Clerico; G Deb; C Dominici; P Fidani; A Donfrancesco
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

6.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.

Authors:  R Sposto; I J Ertel; R D Jenkin; C P Boesel; J L Venes; J A Ortega; A E Evans; W Wara; D Hammond
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

7.  MOPP regimen as primary chemotherapy for brain tumors in infants.

Authors:  J van Eys; A Cangir; D Coody; B Smith
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

8.  Adjuvant chemotherapy for medulloblastoma.

Authors:  S McIntosh; M Chen; P A Sartain; C Duncan; R Fishburn; E H Klatskin; A D Schwartz; J L Venes
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

9.  Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.

Authors:  B R O'Driscoll; P S Hasleton; P M Taylor; L W Poulter; H R Gattameneni; A A Woodcock
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.